Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Danske Markets, Handelsbanken, Nordea and SEB in connection with Billerud's rights issue
Mandate

Vinge advises Danske Markets, Handelsbanken, Nordea and SEB in connection with Billerud's rights issue

July 27, 2009

Vinge has advised a consortium of banks consisting of Danske Markets, Nordea, Handelsbanken and SEB in connection with Billerud's rights issue of a total of approximately SEK 1000 million with pre-emption rights for Billerud's existing shareholders. The issue is fully guaranteed by Billerud's principal shareholders and the banking consortium. Billerud is listed on NASDAQ OMX Stockholm.
 
Ola Sandersson and Dain Nevonen advised the banking consortium

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026

Vinge has advised IK Partners in connection with the acquisition of Selatek

 Vinge has advised IK Partners (“IK”) in connection with IK X Fund’s acquisition of SELATEK Holding AB (“Selatek”), a leading Swedish technical installation platform, from Amplio Private Equity AB and the minority shareholders.
April 20, 2026